ALNY
Alnylam Pharmaceuticals Inc

4,382
Mkt Cap
$57.37B
Volume
1.01M
52W High
$495.55
52W Low
$205.87
PE Ratio
1,787.85
ALNY Fundamentals
Price
$429.80
Prev Close
$434.23
Open
$436.84
50D MA
$456.15
Beta
0.91
Avg. Volume
1.15M
EPS (Annual)
-$2.18
P/B
242.18
Rev/Employee
$1.01M
Loading...
Loading...
News
all
press releases
Swiss National Bank Purchases 29,600 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
Swiss National Bank raised its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 8.1% during the second quarter, according to its most recent disclosure with the...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Legal & General Group Plc Sells 8,340 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
Legal & General Group Plc reduced its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 0.9% in the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·2d ago
News Placeholder
Alnylam Pharmaceuticals, Inc. $ALNY Shares Acquired by Ensign Peak Advisors Inc
Ensign Peak Advisors Inc increased its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 24.5% during the 2nd quarter, according to the company in its most recent...
MarketBeat·3d ago
News Placeholder
American Century Companies Inc. Grows Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY
American Century Companies Inc. grew its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 1.9% during the 2nd quarter, according to its most recent Form 13F filing...
MarketBeat·3d ago
News Placeholder
Westfield Capital Management Co. LP Lowers Position in Alnylam Pharmaceuticals, Inc. $ALNY
Westfield Capital Management Co. LP cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 2.7% during the 2nd quarter, according to its most recent disclosure...
MarketBeat·4d ago
News Placeholder
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years
read more...
Benzinga·4d ago
News Placeholder
Insider Selling: Alnylam Pharmaceuticals (NASDAQ:ALNY) CEO Sells 10,000 Shares of Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Get Free Report) CEO Yvonne Greenstreet sold 10,000 shares of the stock in a transaction that occurred on Thursday, November 13th. The shares were sold at...
MarketBeat·5d ago
News Placeholder
Eagle Health Investments LP Cuts Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY
Eagle Health Investments LP lessened its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 29.8% during the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·5d ago
News Placeholder
Nomura Asset Management Co. Ltd. Boosts Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY
Nomura Asset Management Co. Ltd. lifted its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 5.2% in the 2nd quarter, according to its most recent Form 13F filing...
MarketBeat·6d ago
News Placeholder
Raiffeisen Bank International AG Purchases New Holdings in Alnylam Pharmaceuticals, Inc. $ALNY
Raiffeisen Bank International AG purchased a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·7d ago

Latest ALNY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.